Infectious Disease

  • “Without a doubt, the support from the Georgia CTSA changed the trajectory of my career. It connected me to mentors, protected time and matched me with clinical research which is so important to me,” says Colleen S. Kraft, MD, MSc. Known as one of Emory’s leading infectious disease experts, Colleen S. Kraft, MD, MSc, is no stranger to today’s media outlets and the medical community for her role as
  • Stanford Medicine Office of Community Engagement
    Stanford University

    Join Stanford Medicine | Office of Community Engagement for a COVID-19 COMMUNITY TOWN HALL this Thursday, May 27th | 3:30-5:00 PM PDT What's on the horizon? Address Emerging Issues Around COVID-19 Vaccines for Children, Variants of the Virus, and Mask Guidelines Online Event | Register Today! Spanish Translation Available on Zoom Only FEATURED SPEAKERS • Yvonne (Bonnie) A. Maldonado, MD, FAAP

  • Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (CPIC)

    The Congenital and Perinatal Infections Consortium (CPIC) is focused on reducing the morbidity and mortality of rare viral infections such as congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal viral sepsis caused by enteroviruses (EVs) and the related human parechoviruses (HPeVs). These infections have been grouped together because of their

  • Georgetown University
    Howard University
    George Washington University

    This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current landscape of clinical trials. The focus for this meeting was “COVID-19: the Virus, Preparedness in the

  • -
    Children's Research Institute

    We are excited to invite you to the 2nd Annual Children's National-NIAID Symposium! The Children's National and the National Institute of Allergy and Infectious Diseases (NIAID) partnership focuses on pediatric studies of significant interest to investigators at both institutions. This collaboration is framed and supported through a supplemental award to the Clinical and Translational Science